Considerations for a Bone Marrow Transplant What are the pros and cons of continuing CLL therapies versus having a bone marrow transplant (BMT)? CLL expert Dr. Philip Thompson from MD Anderson Cancer Center, discusses this common dilemma. BMTs are the only treatment ever proven to achieve long-term remission in high-risk CLL patients. However, Dr. Thompson shares reasons to avoid a BMT if possible and to pursue current clinical trials. Sponsored by CLL Global Research Foundation, which received educational grants from AbbVie and Genentech. Get email alerts | Subscribe on YouTube | Like on Facebook | Follow on Twitter | Follow on Google+ |